Education
About Us
Working with TipRanks
Follow Us
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.27M | $ 1.38M | $ 375.00K | $ 0.00 | $ 0.00 |
| Gross Profit | $ 123.00K | $ 120.00K | $ 355.00K | $ -297.00K | $ 0.00 |
| Operating Income | $ -67.25M | $ -171.78M | $ -159.65M | $ -105.89M | $ -82.30M |
| EBITDA | $ -44.16M | $ -165.42M | $ -157.22M | $ -107.00M | $ -82.11M |
| Net Income | $ -59.60M | $ -179.05M | $ -165.76M | $ -106.93M | $ -82.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 29.85M | $ 65.22M | $ 193.72M | $ 232.97M | $ 213.12M |
| Total Assets | $ 38.34M | $ 73.70M | $ 205.85M | $ 239.44M | $ 219.94M |
| Total Debt | $ 102.95M | $ 101.38M | $ 94.16M | $ 1.40M | $ 1.64M |
| Net Debt | $ 73.09M | $ 36.16M | $ -99.57M | $ -231.57M | $ -211.48M |
| Total Liabilities | $ 131.44M | $ 130.21M | $ 129.08M | $ 17.77M | $ 13.24M |
| Stockholders' Equity | $ -93.10M | $ -56.51M | $ 76.78M | $ 221.67M | $ 206.70M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.03M | $ -155.03M | $ -135.48M | $ -82.60M | $ -66.67M |
| Operating Cash Flow | $ -72.03M | $ -155.01M | $ -135.34M | $ -82.15M | $ -66.35M |
| Investing Cash Flow | $ 0.00 | $ -20.00K | $ -139.00K | $ -445.00K | $ -316.00K |
| Financing Cash Flow | $ 36.66M | $ 26.52M | $ 96.24M | $ 102.45M | $ 247.36M |
Bioxcel Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.